Cargando…

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation

Natural killer (NK) cells contribute to the first line of defense against viruses and to the control of tumor growth and metastasis spread. The discovery of HLA class I specific inhibitory receptors, primarily of killer Ig-like receptors (KIRs), and of activating receptors has been fundamental to un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pende, Daniela, Falco, Michela, Vitale, Massimo, Cantoni, Claudia, Vitale, Chiara, Munari, Enrico, Bertaina, Alice, Moretta, Francesca, Del Zotto, Genny, Pietra, Gabriella, Mingari, Maria Cristina, Locatelli, Franco, Moretta, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558367/ https://www.ncbi.nlm.nih.gov/pubmed/31231370 http://dx.doi.org/10.3389/fimmu.2019.01179

Ejemplares similares

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
por: Locatelli, Franco, et al.
Publicado: (2013)

Exploiting Human NK Cells in Tumor Therapy
por: Vacca, Paola, et al.
Publicado: (2020)

Natural killer cells: From surface receptors to the cure of high‐risk leukemia (Ceppellini Lecture)
por: Falco, Michela, et al.
Publicado: (2019)

How melanoma cells inactivate NK cells
por: Pietra, Gabriella, et al.
Publicado: (2012)

Characterization of KIR (+) NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C
por: Meazza, Raffaella, et al.
Publicado: (2022)

NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation
por: Vacca, Paola, et al.
Publicado: (2016)

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
por: Carrega, Paolo, et al.
Publicado: (2009)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Impact of HCMV Infection on NK Cell Development and Function after HSCT
por: Della Chiesa, Mariella, et al.
Publicado: (2013)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
por: Carlomagno, Simona, et al.
Publicado: (2017)

Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia
por: Meazza, Raffaella, et al.
Publicado: (2020)

Transplantation and innate immunity: the lesson of natural killer cells
por: Bertaina, Alice, et al.
Publicado: (2009)

Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function
por: Damele, Laura, et al.
Publicado: (2018)

Late Development of FcεRγ(neg) Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients
por: Muccio, Letizia, et al.
Publicado: (2018)

NK Cell-Based Immunotherapy for Hematological Malignancies
por: Sivori, Simona, et al.
Publicado: (2019)

An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More
por: Vitale, Massimo, et al.
Publicado: (2019)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
por: Sivori, Simona, et al.
Publicado: (2020)

NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans
por: Parodi, Monica, et al.
Publicado: (2019)

Human NK cells, their receptors and function [Image: see text]
por: Quatrini, Linda, et al.
Publicado: (2021)

Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua
por: Vacca, Paola, et al.
Publicado: (2018)

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?
por: Della Chiesa, Mariella, et al.
Publicado: (2015)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)

Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
por: Mariotti, F.R., et al.
Publicado: (2020)

Identification and Molecular Cloning of P75/Airm1, a Novel Member of the Sialoadhesin Family That Functions as an Inhibitory Receptor in Human Natural Killer Cells
por: Falco, Michela, et al.
Publicado: (1999)

Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
por: Parodi, Monica, et al.
Publicado: (2018)

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes
por: Falco, Michela, et al.
Publicado: (2022)

TLR/NCR/KIR: Which One to Use and When?
por: Sivori, Simona, et al.
Publicado: (2014)

NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily
por: Cantoni, Claudia, et al.
Publicado: (1999)

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
por: Colomar-Carando, Natalia, et al.
Publicado: (2022)

Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?
por: Damele, Laura, et al.
Publicado: (2022)

Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance?
por: Damele, Laura, et al.
Publicado: (2020)

Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua
por: Vacca, Paola, et al.
Publicado: (2019)

NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy?
por: Vacca, Paola, et al.
Publicado: (2013)

Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
por: Gaggero, Silvia, et al.
Publicado: (2018)

Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function
por: Manzini, Claudia, et al.
Publicado: (2016)

p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
por: Sivori, Simona, et al.
Publicado: (1997)

Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
por: Morandi, Barbara, et al.
Publicado: (2012)

Uptake of CCR7 by KIR2DS4(+) NK Cells Is Induced upon Recognition of Certain HLA-C Alleles
por: Pesce, Silvia, et al.
Publicado: (2015)

The Emerging Role of HLA-E-Restricted CD8(+) T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors
por: Pietra, Gabriella, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rkvtn513davkv3im5bmo0p0g9k